The Dirección General de Medicamentos, Insumos y Drogas (Digemid) has issued a sanitary alert after identifying falsified pharmaceuticals across four establishments in Chiclayo.
This regulatory action, documented in the Alerta DIGEMID N.° 137-2026, confirms that the seized products failed to meet necessary commercialization standards.
While official records indicate specific expiration dates for these medications, the regulator said that the identified batches do not correspond to those distributed by the authorized sanitary registration holders. As reported by wapa.pe, the investigation revealed that some labeled expiration dates, such as those on Apronax 550 mg, do not match the original manufacturer’s data.
The affected inventory was discovered during national supervision efforts within the province of Chiclayo, department of Lambayeque. Local pharmacies impacted include Botica Biofarma in the district of Lagunas, Botica Arlet Farma and Botica Salud y Bienestar in Pomalca, and Farmacia Isabel in the district of José Leonardo Ortiz, according to Wapa.
The seized stock includes several widely used products:
| Medication | Identified Batches | Stated Expiration |
|---|---|---|
| Apronax 550 mg | 20702534, 20302555 | July 2027, March 2028 |
| Dolo Neurobion NF | 2120353 | December 2026 |
| Dolo Neurobion Forte | M52725-1, M32936, 160057901 | May 2027, December 2027, December 2027 |
Dioxaflex CB Plus soft capsules were also identified among the falsified goods, though specific batch numbers were not provided in the alert. The authority has urged the public to verify the lot numbers and registration status of all medical products before purchase.
Consumers are explicitly advised to “avoid the purchase or use of those that present suspicions of contamination, alteration, falsification or adulteration, as well as those that are marketed without having the corresponding sanitary registration.”